CARB-X LAUNCHES NEW FUNDING ROUND TO FILL MAJOR R&D GAPS IN GLOBAL PIPELINE
06 March 2024
The Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) announced today a funding solicitation with four distinct product themes:
- THERAPEUTICS FOR INFECTIONS CAUSED BY GRAM-NEGATIVE PATHOGENS
- PREVENTION FOR INVASIVE DISEASE
- DIAGNOSTICS FOR NEONATAL SEPSIS
- PROOF-OF-CONCEPT FOR NOVEL SAMPLE TYPES FOR DIAGNOSING LOWER-RESPIRATORY-TRACT INFECTIONS
Target product profiles and minimal acceptable criteria for all funding calls will be defined and available on carb-x.org.
Expressions of interest for all themes may be submitted during these timeframes:
- 18 March 2024 at 10:00 ET – 29 March 2024 at 23:59 ET
- 23 September 2024 at 10:00 ET – 4 October 2024 at 23:59 ET
Further reading: CARB-X
Author(s): CARB-X
Smart Innovations
AMR NEWS
Every two weeks in your inbox
Because there should be one newsletter that brings together all One Health news related to antimicrobial resistance: AMR NEWS!